Restless legs syndrome: Manifestations in aging and dementia

Geriatric Sleep Medicine

Volumn , Issue , 2008, Pages 197-208

  Bliwise, Donald L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84906844159     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (88)

1. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4(2):101-119.
2. Bjorvatn B, Leissner L, Ulfberg J, et al. Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries. Sleep Med 2005; 6(4):307-312.
3. Ulfberg J, Nystrom B, Carter N, et al. Prevalence of restless legs syndrome among men aged 18 to 64 years: An association with somatic disease and neuropsychiatric symptoms. Mov Disord 2001; 16(6):1159-1163.
4. Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: Prevalence and association among Canadians. Sleep 1994; 17(8):739-743.
5. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160(14):2137-2141.
6. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53(1):547-554.
7. Van De Vijver DA, Walley T, Petri H. Epidemiology of restless legs syndrome as diagnosed in UK primary care. Sleep Med 2004; 5(5):435-440.
8. Tison F, Crochard A, Leger D, et al. Epidemiology of restless legs syndrome in French adults: A nationwide survey: The INSTANT Study. Neurology 2005; 65(2):239-246.
9. Wenning GK, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort):Apopulation-based study. Lancet Neurol 2005; 4(12):815-820.
10. Rothdach AJ, Trenkwalder C, Haberstock J, et al. Prevalence and risk factors of RLS in an elderly population: The MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000; 54(5):1064-1068.
11. Nichols DA, Allen RP, Grauke JH, et al. Restless legs syndrome symptoms in primary care: A prevalence study. Arch Intern Med 2003; 163(19):2323-2329.
12. Berger K, Luedemann J, Trenkwalder C, et al. Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164(2):196-202.
13. Allen RP, Walters AS, Montplaisir J, et al. Restless legs syndrome prevalence and impact:REST general population study. Arch Intern Med 2005; 165(11):1286-1292.
14. Hogl B, Kiechl S, Willeit J, et al. Restless legs syndrome: A community-based study of prevalence, severity, and risk factors. Neurology 2005; 64(11):1920-1924.
15. Tan EK, Seah A, See SJ, et al. Restless legs syndrome in an Asian population: A study in Singapore. Mov Disord 2001; 16(3):577-579.
16. Mizuno S, Miyaoka T, Inagaki T, et al. Prevalence of restless legs syndrome in noninstitutionalized Japanese elderly. Psychiatry Clin Neurosci 2005; 59(4):461-465.
17. Sevim S, Dogu O, Camdeviren H, et al. Unexpectedly low prevalence and unusual characteristics of RLS in Mersin, Turkey. Neurology 2003; 61(11):1562-1569.
18. Kim J, Choi C, Shin K, et al. Prevalence of restless legs syndrome and associated factors in the Korean adult population: The Korean Health and Genome Study. Psychiatry Clin Neurosci 2005; 59(3):350-353.
19. Rijsman R, Neven AK, Graffelman W, et al. Epidemiology of restless legs in The Netherlands. Eur J Neurol 2004; 11(9):607-611.
20. Kageyama T, Kabuto M, Nitta H, et al. Prevalences of periodic limb movement-like and restless legs-like symptoms among Japanese adults. Psychiatry Clin Neurosci 2000; 54(3):296-298.
21. Brody JA, Schneider EL. Diseases and disorders of aging: An hypothesis. J Chronic Dis 1986; 39(11):871-876.
22. Phillips B, Hening W, Britz P, et al. Prevalence and correlates of restless legs syndrome:Results from the 2005 National Sleep Foundation Poll. Chest 2006; 129(1):76-80.
23. Mold JW, Vesely SK, Keyl BA, et al. The prevalence, predictors, and consequences of peripheral sensory neuropathy in older patients. J Am Board Fam Pract 2004; 17(5):309-318.
24. Mold JW, Roberts M, Aboshady HM. Prevalence and predictors of night sweats, day sweats, and hot flashes in older primary care patients: an OKPRN study. Ann Fam Med 2004; 2(5):391-397.
25. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005; 28(7):891-898.
26. Sukegawa T, Itoga M, Seno H, et al. Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin Neurosci 2003; 57(3):265-270.
27. Hornyak M, Kopasz M, Berger M, et al. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J Clin Psychiatry 2005; 66(9):1139-1145.
28. Yang C, White DP, Winkelman JW. Antidepressants and periodic leg movements of sleep. Biol Psychiatry 2005; 58(6):510-514.
29. O’Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994; 23(3):200-203.
30. Earley CJ, Connor JR, Beard JL, et al. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology 2000; 54(8):1698-1700.
31. Allen RP, Barker PB, Wehrl F, et al. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 2001; 56(2):263-265.
32. O’Keeffe ST. Secondary causes of restless legs syndrome in older people. Age Ageing 2005; 34(4):349-352.
33. Berger K, von Eckardstein A, Trenkwalder C, et al. Iron metabolism and the risk of restless legs syndrome in an elderly general population-the MEMO-Study. J Neurol 2002; 249(9):1195-1199.
34. Earley CJ, Connor JR, Beard JL, et al. Ferritin levels in the cerebrospinal fluid and restless legs syndrome: Effects of different clinical phenotypes. Sleep 2005; 28(9):1069-1075.
35. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Periodic limb movements in sleep in community-dwelling elderly. Sleep 1991; 14(6):496-500.
36. Youngstedt SD, Kripke DF, Klauber MR, et al. Periodic leg movements during sleep and sleep disturbances in elders. J Gerontol A Biol Sci Med Sci 1998; 53(5):M391-M394.
37. Bixler EO, Kales A, Vela-Bueno A, et al. Nocturnal myoclonus and nocturnal myoclonic activity in the normal population. Res Commun Chem Pathol Pharmacol 1982; 36(1):129-140.
38. Kales A, Bixler EO, Soldatos CR, et al. Biopsychobehavioral correlates of insomnia, part 1: Role of sleep apnea and nocturnal myoclonus. Psychosomatics 1982; 23(6):589-600.
39. Mosko SS, Dickel MJ, Paul T, et al. Sleep apnea and sleep-related periodic leg movements in community resident seniors. J Am Geriatr Soc 1988; 36(6):502-508.
40. Bliwise D, Petta D, Seidel W, et al. Periodic leg movements during sleep in the elderly. Arch Gerontol Geriatr 1985; 4(3):273-281.
41. Youngstedt SD, Kripke DF, Elliott JA, et al. Circadian abnormalities in older adults. J Pineal Res 2001; 31(3):264-272.
42. Mendelson WB. Are periodic leg movements associated with clinical sleep disturbance? Sleep 1996; 19(3):219-223.
43. Montplaisir J, Michaud M, Denesle R, et al. Periodic leg movements are not more prevalent in insomnia or hypersomnia but are specifically associated with sleep disorders involving a dopaminergic impairment. Sleep Med 2000; 1(2):163-167.
44. Karadeniz D, Ondze B, Besset A, et al. Are periodic leg movements during sleep (PLMS) responsible for sleep disruption in insomnia patients? Eur J Neurol 2000; 7(3):331-336.
45. Hornyak M, Trenkwalder C. Restless legs syndrome and periodic limb movement disorder in the elderly. J Psychosom Res 2004; 56(5):543-548.
46. Carrier J, Frenette S, Montplaisir J, et al. Effects of periodic leg movements during sleep in middle-aged subjects without sleep complaints. Mov Disord 2005; 20(9):1127-1132.
47. Bliwise DL, Carskadon MA, Dement WC. Nightly variation of periodic leg movements in sleep in middle aged and elderly individuals. Arch Gerontol Geriatr 1988; 7(4):273-279.
48. Edinger JD, McCall WV, Marsh GR, et al. Periodic limb movement variability in older DIMS patients across consecutive nights of home monitoring. Sleep 1992; 15(2):156-161.
49. Mosko SS, Dickel MJ, Ashurst J. Night-to-night variability in sleep apnea and sleeprelated periodic leg movements in the elderly. Sleep 1988; 11(4):340-348.
50. Coleman RM, Miles LE, Guilleminault CC, et al. Sleep-wake disorders in the elderly:Polysomnographic analysis. J Am Geriatr Soc 1981; 29(7):289-296.
51. Chabli A, Michaud M, Montplaisir J. Periodic arm movements in patients with the restless legs syndrome. Eur Neurol. 2000; 44(3):133-138.
52. Gosselin N, Lanfranchi P, Michaud M, et al. Age and gender effects on heart rate activation associated with periodic leg movements in patients with restless legs syndrome. Clin Neurophysiol 2003; 114(11):2188-2195.
53. Algase DL. Wandering in dementia. Annu Rev Nurs Res. 1999; 17:185-217.
54. Silverstein NM, Flaherty G, Tobin TS. Dementia and Wandering Behavior: Concern for the Lost Elder. New York: Springer Publishing Company, 2002.
55. Logsdon RG, Teri L, McCurry SM, et al. Wandering: A significant problem among community-residing individuals with Alzheimer’s disease. J Gerontol B Psychol Sci Soc Sci 1998; 53(5):P294-P299.
56. Rowe MA, Glover JC. Antecedents, descriptions and consequences of wandering in cognitively-impaired adults and the Safe Return (SR) program. Am J Alzheimers Dis Other Demen 2001; 16(6):344-352.
57. Tractenberg RE, Singer CM, Cummings JL, et al. The Sleep Disorders Inventory: An instrument for studies of sleep disturbance in persons with Alzheimer’s disease. J Sleep Res 2003; 12(4):331-337.
58. Snyder LH, Rupprecht P, Pyrek J, et al. Wandering. Gerontologist 1978; 18:272-280.
59. Nasman B, Bucht G, Eriksson S, et al. Behavioural symptoms in the institutionalized elderly: Relationship to dementia. Inter J Geriatr Psych. 1993; 8(843-849).
60. Kavcic V, Duffy CJ. Attentional dynamics and visual perception: Mechanisms of spatial disorientation in Alzheimer’s disease. Brain 2003; 126(Pt 5):1173-1181.
61. Tetewsky SJ, Duffy CJ. Visual loss and getting lost in Alzheimer’s disease. Neurology 1999; 52(5):958-965.
62. Meguro K, Yamaguchi S, Itoh M, et al. Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer’s disease: A double-tracer PET study. Neurology 1997; 49(4):941-945.
63. Tanaka Y, Meguro K, Yamaguchi S, et al. Decreased striatal D2 receptor density associated with severe behavioral abnormality in Alzheimer’s disease. Ann Nucl Med 2003; 17(7):567-573.
64. Rolland Y, Payoux P, Lauwers-Cances V, et al. A SPECT study of wandering behavior in Alzheimer’s disease. Int J Geriatr Psychiatry 2005; 20(9):816-820.
65. Turjanski N, Lees AJ, Brooks DJ. Striatal dopaminergic function in restless legs syndrome:18F-dopa and 11C-raclopride PET studies. Neurology 1999; 52(5):932-937.
66. Garcia-Borreguero D, Odin P, Serrano C. Restless legs syndrome and PD: A review of the evidence for a possible association. Neurology 2003; 61(6 suppl 3):S49-S55.
67. Martino-Saltzman D, Blasch BB, Morris RD, et al. Travel behavior of nursing home residents perceived as wanderers and nonwanderers. Gerontologist 1991; 31(5):666-672.
68. Tractenberg RE, Singer CM, Kaye JA. Characterizing sleep problems in persons with Alzheimer’s disease and normal elderly. J Sleep Res. 2006; 15:97-103.
69. Pearson VE, Allen RP, Dean T, et al. Cognitive deficits associated with restless legs syndrome (RLS). Sleep Med 2006; 7(1):25-30.
70. Krishnan PR, Bhatia M, Behari M. Restless legs syndrome in Parkinson’s disease: A casecontrolled study. Mov Disord 2003; 18(2):181-185.
71. Ondo WG, Vuong KD, Jankovic J. Exploring the relationship between Parkinson’s disease and restless legs syndrome. Arch Neurol 2002; 59(3):421-424.
72. Nomura T, Inoue Y, Miyake M, et al. Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson’s disease. Mov Disord 2005.
73. Tan EK, Lum SY, Wong MC. Restless legs syndrome in Parkinson’s disease. J Neurol Sci 2002; 196(1-2):33-36.
74. Micheli F, Cersosimo MG, Wooten GF. Neurochemistry and neuropharmacology of Parkinson’s disease. In: Watts RL, Koeller WC, eds. Movement Disorders: Neurologic Principles and Practice, 2nd ed. New York: McGraw-Hill, 2004:197-207.
75. Rye DB. Parkinson’s disease and RLS: The dopaminergic bridge. Sleep Med 2004; 5(3):317-328.
76. Linke R, Eisensehr I, Wetter TC, et al. Presynaptic dopaminergic function in patients with restless legs syndrome: Are there common features with early Parkinson’s disease? Mov Disord 2004; 19(10):1158-1162.
77. Pittock SJ, Parrett T, Adler CH, et al. Neuropathology of primary restless leg syndrome:Absence of specific tau- and alpha-synuclein pathology. Mov Disord 2004; 19(6):695-699.
78. Agargun MY, Kara H, Ozbek H, et al. Restless legs syndrome induced by mirtazapine. J Clin Psychiatry 2002; 63(12):1179.
79. Bahk WM, Pae CU, Chae JH, et al. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci 2002; 56(2):209-210.
80. Brown LK, Dedrick DL, Doggett JW, et al. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005; 6(5):443-450.
81. Pinninti NR, Mago R, Townsend J, et al. Periodic restless legs syndrome associated with quetiapine use: A case report. J Clin Psychopharmacol 2005; 25(6):617-618.
82. Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999; 19(5):478-479.
83. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002; 35(3):109-111.
84. Meguro K, Meguro M, Tanaka Y, et al. Risperidone is effective for wandering and disturbed sleep/wake patterns in Alzheimer’s disease. J Geriatr Psychiatry Neurol 2004; 17(2):61-67.
85. Katz IR, Rupnow M, Kozma C, et al. Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: Secondary analysis of a doubleblind, placebo-controlled trial. Am J Geriatr Psychiatry 2004; 12(5):499-508.
86. Cohrs S, Rodenbeck A, Guan Z, et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berl) 2004; 174(3):421-429.
87. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials. JAMA 2005; 294(15):1934-1943.
88. Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001; 58(12):1161-1167.